000837959 001__ 837959
000837959 005__ 20210129231451.0
000837959 0247_ $$2Handle$$a2128/15657
000837959 037__ $$aFZJ-2017-06720
000837959 041__ $$aEnglish
000837959 1001_ $$0P:(DE-Juel1)133468$$aDahmen, Volker$$b0$$ufzj
000837959 1112_ $$a27th Annual Congress of the European Association of Nuclear Medicine and 5th International Symposium on Targeted Radionuclide-therapy and Dosimetry$$cGöteborg$$d2014-10-18 - 2014-10-22$$gEANM and ISTARD$$wSchweden
000837959 245__ $$aEnhanced cyto- and genotoxic effects of Auger electron emitter-labeled DNA-Triplex-forming oligonucleotides in vitro
000837959 260__ $$c2014
000837959 3367_ $$033$$2EndNote$$aConference Paper
000837959 3367_ $$2DataCite$$aOther
000837959 3367_ $$2BibTeX$$aINPROCEEDINGS
000837959 3367_ $$2DRIVER$$aconferenceObject
000837959 3367_ $$2ORCID$$aLECTURE_SPEECH
000837959 3367_ $$0PUB:(DE-HGF)6$$2PUB:(DE-HGF)$$aConference Presentation$$bconf$$mconf$$s1508748734_30575$$xAfter Call
000837959 520__ $$aThe efficacy of DNA-targeting radionuclide therapies might be strongly enhanced by employing short range particleemitter.However, the therapeutic use of radionuclides requests a thorough radiation dosimetry especially whenshort-range particles are released. In this study we compared the ß-emitter P-32 and the Auger electron emitter I-125in terms of biological effectiveness per decay and per unit dose when located in the close proximity to the DNA byusing Triplex-forming oligonucleotides (TFO).TFO bind to the DNA double helix in a sequence specific manner. Therefore, TFO seem to be a suitable carrier forradionuclides emitting short-range electrons to damage exclusively targeted DNA sequences. We investigatedclonogenicity (colony-forming assay; CFA) in the human squamous carcinoma cell line II (SCL-II) and the induction ofDNA double strand breaks (DSB; 53BP1 foci assay) after exposure with P-32 or I-125 labeled TFO for differentnumbers of accumulated decays. The employed TFO targeted a specific DNA sequence located in the glyceraldehyde3-phosphate dehydrogenase (GAPDH) gene.Results: I-125-labeled TFO binding to single targets were shown to induce a pronounced decrease in cell survival andan increase of DSB with increasing numbers of accumulated decays per cell. The reduction in cell survival asmeasured in the CFA reached the D37 value at ~ 350 accumulated decays per cell, equivalent to ~ 1.2 Gy cellnucleus dose. Using the same TFO but labeled with P-32 revealed neither a significant decrease of the survivalfraction nor an increase of the DSB rate in SCL-II cells up to ~ 4,000 accumulated decays per cell which is equivalentto ~ 1 Gy cell nucleus dose.Summary & Conclusions: The reduction of cell survival and the increase of DNA damage proved to be much morepronounced in I-125-TFO transfected cells than observed after exposure with the P-32-labeled TFO per decay and perdose unit. This can be explained by the high number of low energy Auger electrons emitted by I-125 per decay,leading to a high ionization density in the immediate vicinity of the decay site, probably producing very complex DNAlesions, overcharging the cellular DNA-repair mechanisms.
000837959 536__ $$0G:(DE-HGF)POF3-899$$a899 - ohne Topic (POF3-899)$$cPOF3-899$$fPOF III$$x0
000837959 65027 $$0V:(DE-MLZ)SciArea-160$$2V:(DE-HGF)$$aBiology$$x0
000837959 7001_ $$0P:(DE-Juel1)156306$$aReiter, Stefan$$b1
000837959 7001_ $$0P:(DE-Juel1)133341$$aPomplun, Ekkehard$$b2
000837959 7001_ $$0P:(DE-Juel1)133469$$aKriehuber, Ralf$$b3$$eCorresponding author$$ufzj
000837959 8564_ $$uhttps://juser.fz-juelich.de/record/837959/files/FZJ-2017_06720_oral_RKriehuber.pdf$$yOpenAccess
000837959 8564_ $$uhttps://juser.fz-juelich.de/record/837959/files/FZJ-2017_06720_oral_RKriehuber.gif?subformat=icon$$xicon$$yOpenAccess
000837959 8564_ $$uhttps://juser.fz-juelich.de/record/837959/files/FZJ-2017_06720_oral_RKriehuber.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000837959 8564_ $$uhttps://juser.fz-juelich.de/record/837959/files/FZJ-2017_06720_oral_RKriehuber.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000837959 8564_ $$uhttps://juser.fz-juelich.de/record/837959/files/FZJ-2017_06720_oral_RKriehuber.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000837959 8564_ $$uhttps://juser.fz-juelich.de/record/837959/files/FZJ-2017_06720_oral_RKriehuber.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000837959 909CO $$ooai:juser.fz-juelich.de:837959$$pdriver$$pVDB$$popen_access$$popenaire
000837959 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133468$$aForschungszentrum Jülich$$b0$$kFZJ
000837959 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133469$$aForschungszentrum Jülich$$b3$$kFZJ
000837959 9131_ $$0G:(DE-HGF)POF3-899$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000837959 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000837959 920__ $$lyes
000837959 9201_ $$0I:(DE-Juel1)S-US-20090406$$kS-US$$lSicherheit und Strahlenschutz, Umgebungsüberwachung,Strahlenbiologie$$x0
000837959 980__ $$aconf
000837959 980__ $$aVDB
000837959 980__ $$aUNRESTRICTED
000837959 980__ $$aI:(DE-Juel1)S-US-20090406
000837959 9801_ $$aFullTexts